Introduction
Measurement of aluminium in serum, water and dialysis fluids is recognised to be of clinical significance in the surveillance of patients undergoing peritoneal or haemodialysis for chronic renal failure. Approximately 0·7% of these patients suffer from dialysis demential and there is evidence to implicate aluminium as a causative agent. 2 -4 Symptoms of encephalopathy were first described by Alfrey et al. but it was subsequently realised that the syndrome also features osteomalacic osteodystrophy, anaemia,. malaise, gastrointestinal symptoms, and possibly cardio-toxicity." Death usually occurs within a few months of onset of symptoms and patients dying of dialysis encephalopathy have raised brain aluminium concentration compared with dialysis patients dying from other causes." Chelation therapy with desferrioxamine has recently been used with some success.f
The most important source of aluminium in these patients appears to be the water used for dilution of the dialysis solution." 10 In addition, the salts used for preparation of dialysis concentrates are a potential source of exposure!' and aluminium-based oral hypophosphataemic agents are administered to most dialysis patients. Whatever the source, it is necessary to monitor serum concentrations in dialysis patients both to diagnose aluminium toxicity and to assess the effectiveness of preventitive proce-dures or of chelation therapy. The concentration of aluminium in the serum of patients with the dialysis dementia syndrome can be well below 100 I!g1L (3·7 I!moVL) ie, no more than five times the upper limit of some reference ranges quoted for a healthy population.F The time at which the symptoms appear following initiation of haemodialysis against aluminiumcontaminated fluids is very variable but is typically 6-24 months. Therefore, in a patientmonitoring programme, changes in aluminum concentration of 25 IlglL (approximately 1·0 I!moVL) or less must be measurable with certainty. The importance of these aluminium measurements is well appreciated and if the recommendations of an EEC directive relating to protection of dialysis patients from aluminium exposure is accepted, monitoring of aluminium concentrations in blood, water and dialysis solutions will become mandatory.P For such monitoring programmes to be effective, however, analytical methods must be accurate and precise. Colorimetric or fluorometric'" methods may be appropriate for samples of high aluminium concentration or large volume but for a detection limit of 10 1!g!L (0,37 urnol/L), essential for clinical purposes, electrothermal atomic absorption spectrometry is the method of choice. Despite the sophisticated equipment available for this techni~e and the many published methods' 2U accurate, precise aluminiun. analysis remains difficult. Quoted reference ranges therefore vary the upper limit enormously for a healthy population; these have been given as 92 IJ-g/L (3,41 j!moVL) and 5 IJ-g1L (0·19 IJ-moVL). 18. 19 Such discrepancies render the interpretation of results difficult. To assess laboratory performance for the determination of the metal, serum aluminium was added to the repertoire of the Guildford Trace Elements External Quality Assessment Scheme in 1980; this review attempts to summarise the results of this scheme and discuss its implications. Initially only six laboratories participated in this programme but with the increasing awareness of aluminium toxicity, the number had increased to more than 30 by the end of 1983 and more have enrolled since. These laboratories are situated in 12 different countries.
Methods

OPERATION OF QUALITY ASSESSMENT
SCHEME
For each 6-monthly cycle of the scheme, nine different pools augmented with known amounts of analytes are prepared from sterile donor horse serum which has been pre-treated with Chelex 100 ion-exchange resin. One pool is left unspiked to allow calculation of recovery of added analytes. Participant laboratories receive three aliquots (2 mL) monthly so that nine duplicate samples are distributed in the same random order to each laboratory during the cycle. Aliquots are stored at -20°C prior to despatch. Full details of the scheme have been described previously.P Since October 1983 pools for aluminium determination have been prepared separately, pretreatment of serum with Chelex 100 resin being omitted to avoid possible matrix changes.
Laboratories receive two different types of report. Monthly reports list results submitted for samples recently distributed giving the mean, standard deviation, and coefficient of variation (after omission of results outside the range 'Mean±3 SD'), and display the distribution as a histogram. A 6-monthly report gives an assessment of performance based on the results returned by each laboratory for each of the 18 samples distributed during that period. This report tabulates the proximity of results reported by that laboratory to the consensus mean values, the difference between results obtained for different aliquots of the same pool distributed on two different occasions and the recovery of added aluminium. Recovery data are based on the endogenous value submitted by the individual laboratory and the amount of aluminium added. As recommended by Whitehead 22 a score is derived from these calculations so that performance between laboratories can be compared. A target score which represents a desirable standard of analytical performance has been proposed. ADDITIONAL 
STUDIES
In addition to assessment of laboratory performance other studies were undertaken to evaluate the influence of methodological differences, standardisation and the quality of the distributed samples on the spread of results submitted. Information concerning the methodologies used in different laboratories was obtained by means of a questionnaire. Standardisation was investigated by inter-laboratory comparison of solution of aluminium nitrate (1 mg Al per mL in 1 M nitric acid). Aliquots were sent to eight laboratories and participants asked to compare a series of working standards prepared from-this solution with a similar series of standards prepared from their own stock solution.
To determine whether the quality of the samples affected the spread of the results two experiments were performed. Firstly, a participating laboratory supplied aliquots of its own internal quality control material and these samples were distributed for analysis together with three samples prepared for the Guildford Quality Assessment Scheme. Secondly, on three occasions, samples were pre-assayed (in single analytical batches) in the authors' laboratory prior to distribution in the scheme and the spread of results compared to that of results returned by recipient laboratories.
Results
EXTERNAL QUALITY ASSESSMENT SCHEME
During the first 2 years of the serum aluminium programme only three specialist laboratories regularly returned results. Thus, assessment of performance based upon calculations of the group mean was of limited value. As more laboratories joined the scheme it became evident that, even after exclusion of results of more than 3 SD from the mean, the variation in concentrations reported was very large. Table 1 shows an example of results obtained for a representative 6-monthly period (April-September, 1983). The mean percentage recoveries (based on the endogenous value and Mean ""mol/L SD ""moVL
)..
i2'
:3 the added aluminium) were between 73·5 and 124%, and the coefficients of variation varied from 8·8% to 69·3%. Mean coefficients of variation at different concentrations of aluminium are shown in Fig. 1 , which also shows the changes in performance of laboratories during the period of the scheme. The individual performance of different laboratories within the scheme is very variable. Table 2 shows the proportion of analytical results falling within predetermined limits from the consensus mean, of the best (A) and worst (B) laboratories regularly submitting results during the period, October 1981-September 1983. The targets suggested as indicators of good performance are that 60% of results should fall within the inner limits (approximately ±5% of the mean) and 80% of the results within the outer limits (approximately 10% of the mean). Even the best laboratory (A) failed to meet these criteria.
METHODOLOGY AND INSTRUMENT SURVEY
The survey of equipment and methodology revealed that in the 16 laboratories, instruments from five manufacturers were in use. All these 60 !!-40 > 17 where the temperature is rapidly taken to 700°C and then slowly increased to 1400°C was the most popular ashing procedure. This programme allows for the removal of interfering inorganic constituents Number of results  6  6  5  5  5  Mean umol/L  1·04  1·59  2·42  2·73  6·50  SO J.'ffiollL  0·52  0·49  0·35  0·37  1·40  CV %  50  31  14  14 21 
"Samples were analysed within a single analytical batch for each concentration investigated.
without loss of precision. Atomisation temperatures were from 2500°C to 2800°C. Most laboratories diluted samples 2-1O-fold before analysis. Diluents included water and Triton X100 with or without additives (magnesium nitrate, nitric acid, diammonium hydrogen phosphate).
INVESTIGATION OF STANDARDISATION
The paired standard curves prepared from different aluminium nitrate solutions are shown in Fig. 2 .
ASSESSMENT OF QUALITY OF SAMPLES Table 3 summarises the results reported by participants for the Guildford Trace Elements Quality Assessment samples (nos 1-3) and for the samples provided from a different laboratory where they had been used as internal quality control materials (nos 4, 5). The range of reported results was the same for both sets of samples. Results obtained by pre-screening the External Quality Assessment Scheme samples are shown in Table 4 which also gives the results returned by participants who assayed the same specimens.
Discussion
The analytical requirements (accuracy, precision, limit of detection) for an effective patient-monitoring programme have already been stated. This review of results for the serum aluminium external quality assessment programme has demonstrated that there are considerable difficulties in achieving such standards. Our own experience indicates three major problems. The most important is that of contamination (aluminium is notoriously ubiquitous) either during specimen collection or during analysis. Secondly, matrix effects necessitate either the use of elaborate temperature programmes or techniques of standard addition or matrix matching which add to the complexity and duration of the analysis. Finally, the lack of reference materials'P renders difficult the assessment of the accuracy of results obtained by a particular method. Performance of laboratories in the external quality assessment scheme reflects these problems. Coefficients of variation for aluminium analysis were from 10% to 61%, whilst those for more easily assayed trace metals such as copper were from 8% to 13% over the same period (January-December 1983). There was also a very wide variation in the amount of aluminium recovered by the participating laboratories. The spread of results (% CV) at different aluminium concentrations (Fig. 1) appears to be falling significantly as time progresses, particularly at aluminium concentrations greater than 2·0 umol/L, Table 2 demonstrates that some laboratories can perform consistently well, but even the best laboratory does not consistently attain the target performance of the quality assessment scheme.
The survey of instruments and methodologies in 16 of the laboratories participating in the programme revealed that a wide range of instruments and methods were in use. This may contribute to the inter-laboratory differences in results.
Standard curves produced by the eight laboratories investigated demonstrated that, for all but one, the concentrated aluminium solutions in routine use were not significantly different from that sent from Guildford. The wide distribution of results obtained in the trace element quality assessment scheme cannot therefore be attributed to the use of different stock standard solutions.
The wide variability of results submitted does not appear to be due to the quality (at the time of distribution) of the external quality assessment samples. Results obtained from the two human serum samples and the three external quality assessment samples which were distributed together showed a similar variation at equivalent concentrations (Table 3 ). Furthermore the analysis of samples prior to distribution demonstrated that aliquots from a single serum pool were of similar aluminium concentration (Table 4 ). It may be argued that in this experiment concentrations were determined within a single analytical batch using fresh samples whereas results reported by the participants represent data derived from several procedures on specimens of different ages. It is also possible that in sampling from the vial during the pre-distribution analysis, contamination may have been introduced. In the authors' laboratory, however, vials of serum have been stored at 4°C and resampled several times as between-batch control samples. Analytical inter-batch precision (coefficients of variation) was found to be less than 13% and 9% at serum aluminium concentrations of 17 1J.g/L and 73 IJ.g1L (0,63 umol/L and 2·7 umol/L) respectively.
This review has demonstrated that before large scale monitoring of serum aluminium concentrations in dialysis patients can be undertaken with confidence, further improvements in analytical performance are imperative. For the quarterly monitoring of dialysis patients which Aluminium in serum 357 has been suggested'? more rigorous internal quality control will be necessary. To allow comparison of results between patients at different times and in different centres, stringent analytical requirements will need to be set and participation in a recognised external quality assessment scheme mandatory. Analysis of water and dialysis fluids will likewise need to be subjected to stringent quality control.
